Drug Channels

SEPTEMBER 21, 2022

In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. However, buy-and-bill appears to have rebounded substantially at hospitals. Read on for full details and the latest data.

Specialty Pharmacies 97

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 97

Drug Channels

AUGUST 6, 2024

In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies.

Pharmacy 90

Pharmacy Hospitals Marketing Drugs 90

Drug Channels

OCTOBER 12, 2021

specialty pharmacies—via white, brown, and clear bagging—continue to displace buy-and-bill distribution channels for provider-administered oncology drugs. The battle for the specialty patient pits hospitals against insurers—and their respective specialty pharmacies. Hospitals, however, lose profits and face higher costs.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Pharmaceuticals 97

Drug Channels

APRIL 1, 2024

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers.

Pharmacy 98

Pharmacy Hospitals Pharmaceuticals Drugs 98

Drug Channels

JUNE 21, 2022

National Association of Specialty Pharmacy (NASP) 2022 Annual Meeting & Expo. The National Association of Specialty Pharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. www.naspnet.org/annualmeeting.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Nurses Hospitals 98

Drug Channels

AUGUST 18, 2020

Hospitals and health systems are building a major presence in the specialty pharmacy industry. As we demonstrate below, nine out of ten large hospitals now operate a specialty pharmacy. Hospitals and other healthcare providers account for one-third of all U.S. accredited specialty pharmacies.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Regulations 52

Drug Channels

DECEMBER 5, 2023

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

SEPTEMBER 13, 2022

These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to administer the IRA's lower pharmacy reimbursements.

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Drug Channels

DECEMBER 12, 2022

These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to administer the IRA's lower pharmacy reimbursements.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

APRIL 4, 2024

For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. As many of you know, hospitals and health systems have emerged as significant participants in the specialty pharmacy industry. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

Drug Channels

OCTOBER 2, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

JULY 11, 2023

Looks like pharmacy and PBM profiteering within the 340B Drug Pricing Program will never go out of style. Drug Channels Institute’s (DCI) latest analysis reveals that more than 33,000 pharmacy locations —more than half of the entire U.S. Read on for my latest effort to pierce these little webs of 340B opacity.

Pharmacy 74

Pharmacy Marketing Hospitals Drugs 74

Drug Channels

JULY 23, 2020

The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. Our indisputable math exposes the little-understood economics behind specialty pharmacies in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Drugs 52

Drug Channels

JUNE 4, 2024

Meanwhile, employment and salaries in non-retail settings—hospitals, physician offices, outpatient centers, and home healthcare—continued to grow. What’s ahead for 340B-eligible hospitals? These settings now employ one in three U.S. pharmacists. Greener grass—or just different soil?

Hospitals 98

Hospitals Drugs Pharmacy 98

Drug Channels

MAY 17, 2022

Two weeks ago, Paula and I had the pleasure of attending Asembia’s 2022 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. Below, I violate Vegas code and tell you what happened there.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs Hospitals 98

Drug Channels

MARCH 14, 2022

Asembia’s Specialty Pharmacy Summit 2022. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The Specialty Pharmacy Industry Update and Outlook. Gottlieb’s excellent book.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy FDA Science 74

Drug Channels

SEPTEMBER 28, 2021

Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch: Fresh insights about hospitals’ specialty drug profits SSR Update: Drug prices keep dropping My $0.02 Autumn is here! You can also find me on LinkedIn , where I have more than 20,000 followers. d/b/a Drug Channels Institute.

Hospitals 81

Hospitals Biosimilars Pharmacy Drugs 81

Drug Channels

MARCH 25, 2024

P.S. Join my nearly 54,000 LinkedIn followers for daily links to neat stuff.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Hospitals Drugs 75

Drug Channels

OCTOBER 27, 2021

Scream as Blue Cross Blue Shield frightfully overpays hospitals Shocking! PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! Brrr.did you hear that? It’s the biosimilar boom! Believe it or not, U.S You can also find my daily posts on LinkedIn , where I have more than 20,000 followers.

Biosimilars 75

Biosimilars Hospitals Independent Pharmacies Pharmacy 75

Drug Channels

MAY 30, 2023

P.S. Join my more than 41,000 LinkedIn followers for daily links to neat stuff.

Biosimilars 75

Biosimilars Hospitals Pharmacy Drugs 75

FDA Law Blog: Biosimilars

MAY 16, 2024

Houck — Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). The Kentucky hospital resolved the allegations for $4,394,600 and entered into a three-year MOA in November 2021.

Hospitals 59

Hospitals Nurses Compliance Pharmacy 59

Policy Prescription

OCTOBER 22, 2024

Harvard doctors and public health experts recommend using the website PharmacyChecker.com to find international online pharmacies to order more affordable prescription drugs for personal importation when domestic savings strategies fail. Pharmacy discount cards and coupons are freely accessible on sites like GoodRx and RxSaver.

Online Pharmacies 113

Online Pharmacies Pharmacy Drugs FDA Approval 113

Drug Channels

AUGUST 15, 2022

Hospitals accounted for 87% of these skyrocketing 340B purchases. The data tell a familiar story. For 2021, discounted purchases under the 340B program reached a record $43.9 billion —an astonishing $5.9 billion (+15.6%) higher than its 2020 counterpart. billion (+$7.0 billion).

Hospitals 98

Hospitals Drugs Pharmacy 98

Drug Channels

JANUARY 30, 2024

Plus, Dr. Glaucomflecken peeks inside a hospital owned by a private equity firm. Senator Cassidy tries to tackle CVS and Walgreens—and I give you a peek at a Walgreens 340B contract Offsides : To Gen Z, being a pharmacist is cheugy. P.S. A big THANK YOU for all the warm wishes and congratulations on DCI’s acquisition by HMP!

Hospitals 75

Hospitals Pharmacy Drugs Production 75

Drug Channels

JUNE 15, 2021

Drug Channels Institute’s latest review of contract pharmacies in the 340B Drug Pricing Program reveals that an astonishing 30,000 pharmacy locations—half of the entire U.S. pharmacy industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Pharmacy 52

Pharmacy Hospitals Drugs 52

FDA Law Blog: Biosimilars

MAY 30, 2024

The 340B statute requires drug manufacturers to sell certain drugs at discounted ceiling prices to covered entities, which are defined by statute to include certain types of safety net hospitals, health centers, and clinics receiving federal grants. A number of drug companies sued to enjoin enforcement.

Pharmacy 59

Pharmacy Pharmaceuticals Drugs Government 59

Drug Channels

MAY 30, 2022

Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill: SaveonSP gets sued Thoughts on the Medicaid accumulator rule opinion CVS buys AmerisourceBergen’s specialty pharmacy Fresh data on hospitals’ cancer drug profiteering Plus, Dr. Glaucomflecken explains Aetna’s prior authorization policies.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Drugs 97

Drug Channels

JUNE 18, 2024

billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. However, Walgreens disclosed that it also generates about $16 billion in specialty revenues from its retail pharmacies and nearly 300 community-based specialty pharmacy locations. Click here to see the original post from April 2024.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

DECEMBER 16, 2022

Hospitals accounted for 87% of these skyrocketing 340B purchases. The data tell a familiar story. For 2021, discounted purchases under the 340B program reached a record $43.9 billion —an astonishing $5.9 billion (+15.6%) higher than its 2020 counterpart. billion (+$7.0 billion).

Hospitals 97

Hospitals Drugs Pharmacy 97

Drug Channels

MAY 18, 2021

specialty pharmacies. As you will note below, the specialty pharmacy industry remains quite diverse— despite the concentration of dispensing revenues within a small number of companies. It’s time for Drug Channels Institute’s annual update of the number of U.S. Fortunately, I had outstanding research assistance. See photo at right.).

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. Happy Thanksgiving, everyone!

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Biosimilars Drugs 75

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Biosimilars Drugs 75

Drug Channels

SEPTEMBER 23, 2020

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Production 52

Drug Channels

AUGUST 8, 2023

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. I shared my $0.02 How could I not? Click here to read the Drug Channels Institute letter to Senators Thune, Stabenow, Moore Capito, Baldwin, Moran, and Cardin.

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

JULY 14, 2020

It’s time for our annual look at the 340B Drug Pricing Program’s booming pharmacy component. Our exclusive analysis of government data finds that 28,000 pharmacy locations—almost half of the U.S. industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Pharmacy 52

Pharmacy Government Hospitals Drugs 52

Drug Channels

DECEMBER 18, 2020

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Drugs 52